Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 3, 2010, Pages 653-658

  Luo, Yi ^a   Shelly, Lorraine ^a   Sand, Thomas ^a   Chang, George ^a   Jiang, Xian Cheng ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; SMALL MOLECULE TRANSPORT AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPOPROTEIN SECRETION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; CARRIER PROTEINS; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; HEPATOCYTES; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL3; LIPOSOMES; MICE; MICE, KNOCKOUT; MOLECULAR STRUCTURE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID TRANSFER PROTEINS; RECOMBINANT PROTEINS; TRIGLYCERIDES; TRIOLEIN;

EID: 78649535304     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171942     Document Type: Article

References (24)

1. Athar H, Iqbal J, Jiang XC, and Hussain MM (2004) A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer protein. J Lipid Res 45:764-772.
2. Chandler CE, Wilder DE, Pettini JL, Savoy YE, Petras SF, Chang G, Vincent J, and Harwood HJ Jr (2003) CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 44:1887-1901.
3. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AF, Grant FJ, O'Hara PJ, Marcovina SM, and Adolphson JL (1994) Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 269:9388-9391.
4. de Vries R, Dallinga-Thie GM, Smit AJ, Wolffenbuttel BH, van Tol A, and Dullaart RP (2006) Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia 49:398-404.
5. Fang M, Rivas MP, and Bankaitis VA (1998) The contribution of lipids and lipid metabolism to cellular functions of the Golgi complex. Biochim Biophys Acta 1404:85-100.
6. Haghpassand M, Wilder D, and Moberly JB (1996) Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2). J Lipid Res 37:1468-1480.
7. Hamilton RL, Wong JS, Cham CM, Nielsen LB, and Young SG (1998) Chylomicronsized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res 39:1543-1557.
8. Hussain MM, Iqbal J, Anwar K, Rava P, and Dai K (2003) Microsomal triglyceride transfer protein: a multifunctional protein. Front Biosci 8:s500-506.
9. Jamil H, Chu CH, Dickson JK Jr, Chen Y, Yan M, Biller SA, Gregg RE, Wetterau JR, and Gordon DA (1998) Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells. J Lipid Res 39:1448-1454.
10. Jamil H, Gordon DA, Eustice DC, Brooks CM, Dickson JK Jr, Chen Y, Ricci B, Chu CH, Harrity TW, Ciosek CP Jr, et al. (1996) An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci USA 93:11991-11995.
11. Jiang XC, Li Z, Liu R, Yang XP, Pan M, Lagrost L, Fisher EA, and Williams KJ (2005) Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J Biol Chem 280:18336-18340.
12. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, and Tall AR (2001) Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7:847-852.
13. Luo Y, Shelly L, Sand T, Reidich B, Chang G, Macdougall M, Peakman MC, and Jiang XC (2010) Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein B secretion from hepatocytes. J Pharmacol Exp Ther 332:1100-1106.
14. Rava P, Athar H, Johnson C, and Hussain MM (2005) Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein. J Lipid Res 46:1779-1785.
15. Rava P, Ojakian GK, Shelness GS, and Hussain MM (2006) Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins. J Biol Chem 281:11019-11027.
16. Read J, Anderson TA, Ritchie PJ, Vanloo B, Amey J, Levitt D, Rosseneu M, Scott J, and Shoulders CC (2000) A mechanism of membrane neutral lipid acquisition by the microsomal triglyceride transfer protein. J Biol Chem 275:30372-30377.
17. Samyn H, Moerland M, van Gent T, van Haperen R, Metso J, Grosveld F, Jauhiainen M, van Tol A, and de Crom R (2008) Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study. J Lipid Res 49:2504-2512.
18. Schlitt A, Bickel C, Thumma P, Blankenberg S, Rupprecht HJ, Meyer J, and Jiang XC (2003) High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 23:1857-1862.
19. Tall AR and Lalanne F (2003) Phospholipid transfer protein and atherosclerosis. Arterioscler Thromb Vasc Biol 23:1484-1485.
20. Tall AR, Krumholz S, Olivecrona T, and Deckelbaum RJ (1985) Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res 26:842-851.
21. Tollefson JH, Ravnik S, and Albers JJ (1988) Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 29:1593-1602.
22. van Haperen R, Samyn H, Moerland M, van Gent T, Peeters M, Grosveld F, van Tol A, and de Crom R (2008) Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis. PLoS ONE 3:e2255.
23. van Haperen R, van Tol A, van Gent T, Scheek L, Visser P, van der Kamp A, Grosveld F, and de Crom R (2002) Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem 277:48938-48943.
24. Yang XP, Yan D, Qiao C, Liu RJ, Chen JG, Li J, Schneider M, Lagrost L, Xiao X, and Jiang XC (2003) Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler Thromb Vasc Biol 23:1601-1607.